See you in St. Louis, where biologics innovation starts
Here our experts have access to high capital equipment and resources, enabling them to create customized or optimized process development and scale-up techniques for development of bispecific, Fc-fusion, IgG1, IgG4, and various other complex protein-based biologics.
Capabilities and strategies designed for high-quality and timely production, including:
- Cell line development
- Process development
- Analytical and liquid formulation development
- Cell banking
- Commercialization
- Regulatory support for IND/IMPD and BLA submission
- Clinical and commercial manufacturing
4766 LaGuardia Drive
St. Louis, MO 63134-3117